Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-07

Clinical Trial Update: Aripiprazole Effects on Alcohol Drinking and Craving [Phase 3]

View source ↗

Summary

Phase 3 study evaluating aripiprazole for reducing alcohol consumption and cravings in individuals with alcohol dependence; results were posted in July 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence | Phase 3 | Status: COMPLETED | Results posted: 2017-07-07